A股異動丨利爾化學(002258.SZ)漲超7% 草銨膦價格創一年來新高
格隆匯6月24日丨利爾化學(002258.SZ)漲超7%,報18.39元,總市值96.43億元。據百川資訊數據,本週國內草甘膦現貨價格繼續上漲4%至14.5萬元/噸,部分高端報價達到15-15.5萬元/噸,較5月同期上漲近18%,今年以來漲幅近38%,創出一年以來新高。目前,主流供應商訂單充足,95%原粉部分生產商封盤停報,惜售情緒濃厚,對價格形成較強支撐。利爾化學是全球第一大草銨膦企業,年產能超過14萬噸,佔全球的30%。公司廣安基地草銨膦併線工作正有序推進,完成後公司草銨膦成本將大幅降低。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.